UPM Institutional Repository

Lactococcus lactis harbouring Ara h 2.02 alleviates allergen-specific Th2-associated responses in sensitized mice


Citation

Chan, Chong Joo and Yong, Yen Su and Song, Adelene Ai Lian and Abdul Rahim, Raha and In, Lionel Lian Aun and Lim, Renee Lay Hong (2020) Lactococcus lactis harbouring Ara h 2.02 alleviates allergen-specific Th2-associated responses in sensitized mice. Journal of Applied Microbiology, 128 (3). 862 - 874. ISSN 1364-5072; ESSN: 1365-2672

Abstract

Aim: To study the prophylactic effect of recombinant Lactococcus lactis (rLl) harbouring Ara h 2.02 peanut allergen, in sensitized and challenged mice. Methods and results: Ara h 2.02 cDNA was cloned into pNZ8048 for heterologous expression in L. lactis. The purified recombinant allergen showed IgE binding comparable with native Ara h 2. Balb/c mice were fed with either recombinant (rLl), nonrecombinant L. lactis (Ll) or NaHCO3 (Sham) prior to sensitization and challenged with rAra h 2.02, whereas the baseline group was only fed with Ll. Allergen-specific immunoglobulin and splenocyte cytokines responses were determined for each mouse. Mice fed with either Ll or rLl showed significant alleviation of IgE and IgG1 compared to the Sham group. Despite no significant decrease in Th2 (IL-4, IL-13, IL-6) or increase in Th1 (IFN-γ) cytokines, both groups showed lower IL-10 level, while the IL-4 : IFN-γ ratio was significantly lower for rLl compared to Ll group. Conclusions: Oral administration of rLl harbouring Ara h 2.02 demonstrated alleviation of Th2-associated responses in allergen-challenged mice and a possible added allergen-specific prophylactic effect. Significance and impact of the study: Ara h 2.02 coupled with the intrinsic properties of probiotic L. lactis as a delivery vehicle can be explored for the development of a commercially scalable vaccine.


Download File

Additional Metadata

Item Type: Article
Divisions: Faculty of Biotechnology and Biomolecular Sciences
DOI Number: https://doi.org/10.1111/jam.14524
Publisher: Wiley
Keywords: Lactococcus lactis; IgE alleviation; Oral administration; Peanut allergy; Recombinant Ara h 2.02
Depositing User: Ms. Nuraida Ibrahim
Date Deposited: 16 Aug 2021 10:13
Last Modified: 16 Aug 2021 10:13
Altmetrics: http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.1111/jam.14524
URI: http://psasir.upm.edu.my/id/eprint/89540
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item